Post-Doctoral Researcher

The University Health Network, where “above all else the needs of patients come first”, encompasses Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and the Michener Institute of Education. The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of ground breaking firsts and a purpose of “Transforming lives and communities through excellence in care, discovery and learning”, the University Health Network (UHN), Canada’s largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.

Position Summary

MYC is dysregulated in a majority of human cancers and is a key regulator, binding to 15% of the human genome. Successfully targeting MYC would represent a breakthrough in cancer therapy, but due to the intrinsically disordered nature of the MYC protein it has evaded drug development for several decades. Our lab has recently identified an exciting therapeutic opportunity in the PP1-PNUTS phosphatase complex which, when inhibited, leads to MYC hyperphosphorylation and degradation. MYC cannot be inhibited directly, so we are working to inhibit the direct complex formation between MYC and PNUTS. By targeting MYC through essential interactions like that with PNUTS, we are finally able to begin making progress towards the targeting of this undruggable protein, the potential of which is enormous.

We are searching for a highly motivated Post-Doctoral Researcher in a related discipline, such as biochemistry or biophysics. This project will consist of validating and characterizing novel MYC-protein interactions, biophysically and structurally, with a focus on proteins that are essential to MYC oncogenic function. The successful candidate will be working at the Princess Margaret Cancer Centre in conjunction with the Structural Genomics Consortium at the University of Toronto and will benefit from this highly collaborative and interdisciplinary research team.

Duties

In addition to working alongside some of the most talented and inspiring healthcare professionals in the world, UHN offers a wide range of benefits, programs and perks. It is the comprehensiveness of these offerings that makes it a differentiating factor, allowing you to find value where it matters most to you, now and throughout your career at UHN.

UHN uses email to communicate with selected candidates. Please ensure you check your email regularly.

Please be advised that a Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.

UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.

We thank all applicants for their interest, however, only those selected for further consideration will be contacted.